Patents Assigned to EndoMet Biosciences, Inc.
  • Compositions and methods for treating endometriosis
    Patent number: 11884749
    Abstract: Provided herein are peptides that bind ?-catenin, and compositions comprising said peptides. Peptides binding ?-catenin prevent translocation to the nucleus and modulate the canonical Wnt pathway. Also provided herein are methods of using said peptides and compositions in the treatment of tissue-infiltrating conditions including endometriosis.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: January 30, 2024
    Assignee: EndoMet Biosciences, Inc.
    Inventors: Tanya Petrossian, Stephen Fiacco, Tristin Rose, Amanda Hardy, Keerthi Boddupally, Matthew Willmore